跳至主要内容
临床试验/ACTRN12617000124336
ACTRN12617000124336撤回2 期

Efficacy of Insulin Pump Therapy for Reducing Diabetic complications in adults with type 1 diabetes (InsPyReD)

niversity of New South Wales Australia0 个研究点目标入组 60 人开始时间: 2017年1月24日最近更新:
适应症

试验速览

阶段
2 期
状态
撤回
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
All

入选标准

  • History of type 1 diabetes, currently on multiple daily insulin injections but deemed suitable for continuous subcutaneous insulin infusions (CSII/Pump therapy) by treating endocrinologist. 18-45 years of age.

排除标准

  • a. Previous insulin pump therapy
  • b. Severe neuropathy, leading to difficulty with performing neurophysiological assessments.
  • c. Administration of another investigational drug within 30 days prior to randomisation.
  • d. Significant neurological or psychiatric disorders.
  • e. History of other conditions aside from type 1 diabetes that cause neuropathy (e.g end stage kidney disease).
  • f. Known pregnancy.
  • g. Known medical history causing reduced corneal sensation and neurotrophic keratitis (e.g. viral infections, chemical burns, corneal surgery, excessive use of topical anaesthetic, history of fifth nerve palsy and multiple sclerosis).

研究者

发起方
niversity of New South Wales Australia

相似试验